CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 65 enrolled
Drug / intervention
High-Flow Nasal Cannuladevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06458582
NCT06458582N/ACompleted

High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Very Premature Infants: a Prospective Observational Study

Charles University, Czech Republic·interventional·Posted Jun 13, 2024·Updated Nov 12, 2024

In Brief

A clinical study evaluating High-Flow Nasal Cannula for Premature; Infant. Completed, enrolled 65 participants across 1 site.

Detailed Summary

A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize very preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low SpO2.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCzechia
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 13, 2024
Enrollment StartFeb 1, 2021
Primary CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 2.1 years ago

Interventions

High-Flow Nasal Cannuladevice

The intervention involves administering High-Flow Nasal Cannula therapy to very preterm infants immediately after birth.